Liver stiffness in chronic hepatitis C virus infection

被引:3
作者
Mihaila, Romeo-Gabriel [1 ,2 ]
机构
[1] Lucian Blaga Univ Sibiu, Fac Med, Sibiu, Romania
[2] Emergency Cty Clin Hosp Sibiu, Dept Hematol, Sibiu, Romania
关键词
Chronic hepatitis C; Liver fibrosis; Liver stiffness; Shear wave elastography; Transient elastography; ACTING ANTIVIRAL THERAPY; SHEAR-WAVE ELASTOGRAPHY; FORCE IMPULSE ARFI; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; ULTRASOUND ELASTOGRAPHY; NONINVASIVE ASSESSMENT; FIBROSIS ASSESSMENT; HCV; VALUES;
D O I
10.2478/rjim-2018-0034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The severity of liver fibrosis can be assessed noninvasively today by liver stiffness measurements. Vibration-controlled transient elastography, shear wave elastography or magnetic resonance elastography are techniques increasingly used for this purpose. Methods. This article presents the recent advances in the use of new techniques for liver fibrosis assessment in chronic hepatitis C: the correlation between liver stiffness values and liver fibrosis estimated by liver biopsies, the prognosis role of liver stiffness values, their usefulness in monitoring the treatment response, in assessing the severity of portal hypertension and in estimating the presence of esophageal varices. Scientific articles from January 2017 to January 2018 were searched in PubMed and PubMed Central databases, using the terms "liver stiffness" and "hepatitis C". Results. The median liver stiffness values measured with different techniques are not identical, so that FibroScan thresholds cannot be used on any other elastographic machine. The higher the liver's stiffness measurement, the higher the liver-related events in patients with chronic hepatitis C. A liver stiffness measurement over 17 kPa could be an independent predictor for the presence of esophageal varices as well as a spleen with a longitudinal span >= 15 cm for patients with a value of liver stiffness < 17 kPa. A progressive and persistent decrease in liver stiffness is dependent on sustained virological response achievement. The lack of liver stiffness decrease has been associated with relapsers and a low value of liver stiffness at baseline. Conclusion. Liver stiffness provides clues about the severity and evolution of liver disease.
引用
收藏
页码:85 / 98
页数:14
相关论文
共 78 条
[1]   Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study [J].
Afdhal, Nezam H. ;
Bacon, Bruce R. ;
Patel, Keyur ;
Lawitz, Eric J. ;
Gordon, Stuart C. ;
Nelson, David R. ;
Challies, Tracy L. ;
Nasser, Imad ;
Garg, Jyotsna ;
Wei, Lee-Jen ;
McHutchison, John G. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (04) :772-+
[2]   Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older [J].
Akuta, Norio ;
Sezaki, Hitomi ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Saitoh, Satoshi ;
Suzuki, Yoshiyuki ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (01) :91-98
[3]  
American Association for the Study of Liver Diseases
[4]  
Infectious Diseases Society of America, 2018, HCV GUID REC TEST MA
[5]   Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade [J].
Andrea, Bregenzer ;
Anna, Conen ;
Juerg, Knuchel ;
Andree, Friedl ;
Franz, Eigenmann ;
Martin, Naef ;
Peter, Ackle ;
Martin, Roth ;
Andreas, Fux Christoph .
SWISS MEDICAL WEEKLY, 2017, 147
[6]   CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study [J].
Angeles Jimenez-Sousa, Maria ;
Zaida Gomez-Moreno, Ana ;
Pineda-Tenor, Daniel ;
Maria Medrano, Luz ;
Jose Sanchez-Ruano, Juan ;
Fernandez-Rodriguez, Amanda ;
Artaza-Varasa, Tomas ;
Saura-Montalban, Jose ;
Vazquez-Moron, Sonia ;
Ryan, Pablo ;
Resino, Salvador .
CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
[7]  
[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
[8]   Expanding the Baveno VI Criteria for the Screening of Varices in Patients With CompensatedAdvancedChronicLiverDisease [J].
Augustin, Salvador ;
Pons, Monica ;
Maurice, James B. ;
Bureau, Christophe ;
Stefanescu, Horia ;
Ney, Michel ;
Blasco, Helene ;
Procopet, Bogdan ;
Tsochatzis, Emmanuel ;
Westbrook, Rachel H. ;
Bosch, Jaime ;
Berzigotti, Annalisa ;
Abraldes, Juan G. ;
Genesca, Joan .
HEPATOLOGY, 2017, 66 (06) :1980-1988
[9]   Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index [J].
Bachofner, Jacqueline A. ;
Valli, Piero V. ;
Kroeger, Arne ;
Bergamin, Irina ;
Kuenzler, Patrizia ;
Baserga, Adriana ;
Braun, Dominique ;
Seifert, Burkhardt ;
Moncsek, Anja ;
Fehr, Jan ;
Semela, David ;
Magenta, Lorenzo ;
Muellhaupt, Beat ;
Beretta-Piccoli, Benedetta Terziroli ;
Mertens, Joachim C. .
LIVER INTERNATIONAL, 2017, 37 (03) :369-376
[10]   Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease [J].
Bellan, Mattia ;
Sainaghi, Pier Paolo ;
Minh, Margherita Tran ;
Minisini, Rosalba ;
Molinari, Luca ;
Baldrighi, Marco ;
Salmi, Livia ;
Barbaglia, Matteo Nazzareno ;
Castello, Luigi Mario ;
Ravanini, Paolo ;
Avanzi, Gian Carlo ;
Pirisi, Mario .
BIOMARKERS IN MEDICINE, 2018, 12 (01) :27-34